Influence of intracerebral administration of NO agents in dorsal hippocampus (CA1) on cannabinoid state-dependent memory in the step-down passive avoidance test

Physiology and Behavior

Volumn 100, Issue 4, 2010, Pages 297-304

  Nasehi, Mohammad ^a   Piri, Morteza ^b   Jamali Raeufy, Nida ^c   Zarrindast, Mohammad Reza ^c,d,e,f  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c INSTITUTE FOR COGNITIVE SCIENCE STUDIES   (Iran)

^d IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f INSTITUTE FOR STUDIES IN THEORETICAL PHYSICS AND MATHEMATICS IPM   (Iran)

Author keywords

L Arginine; L NAME; Mice; State dependent memory; Step down passive avoidance task; WIN55, 212 2

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; ARGININE; CANNABINOID; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; BENZOXAZINE DERIVATIVE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; ENZYME INHIBITOR; MORPHOLINE DERIVATIVE; NAPHTHALENE DERIVATIVE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EXPLORATORY BEHAVIOR; GROOMING; HEAD MOVEMENT; HIPPOCAMPUS; INFORMATION RETRIEVAL; LOCOMOTION; MALE; MEMORY CONSOLIDATION; MEMORY DISORDER; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; REARING; TASK PERFORMANCE; TRAINING; AGONISTS; ANIMAL; AVOIDANCE BEHAVIOR; CHEMICALLY INDUCED; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECTS; HIPPOCAMPAL CA1 REGION; INBRED MOUSE STRAIN; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MEMORY; PARASITOLOGY;

ANIMALS; ARGININE; AVOIDANCE LEARNING; BENZOXAZINES; CA1 REGION, HIPPOCAMPAL; CANNABINOIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ENZYME INHIBITORS; EXPLORATORY BEHAVIOR; INJECTIONS, INTRAVENTRICULAR; MALE; MEMORY; MEMORY DISORDERS; MICE; MICE, INBRED STRAINS; MORPHOLINES; NAPHTHALENES; NG-NITROARGININE METHYL ESTER; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2;

EID: 77952956963     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2010.02.025     Document Type: Article

References (101)

1. Munro S., Thomas K.L., Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993, 365(6441):61-65.
2. Bisogno T., Maurelli S., Melck D., De Petrocellis L., Di Marzo V. Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes. J Biol Chem 1997, 272:3315-3323.
3. Ryberg E., Larsson N., Sjogren S., Hjorth S., Hermansson N.O., Leonova J., et al. The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol 2007, 152:1092-1101.
4. Mackie K.N.S. Cannabinoid receptors and endocannabinoids: evidence for new players. The AAPS 2006, 8(2):298-306.
5. Izquierdo I., Medina J.H. Correlation between the pharmacology of long-term potentiation and the pharmacology of memory. Neurobiol Learn Mem 1995, 63(1):19-32.
6. Squire L.R. Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans. Psychol Rev 1992, 99(2):195-231.
7. Dragic T., Litwin V., Allaway G.P., Martin S.R., Huang Y., Nagashima K.A., et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996, 381:667-673.
8. Chaperon F., Thiebot M.H. Behavioral effects of cannabinoid agents in animals. Crit Rev Neurobiol 1999, 13(3):243-281.
9. Brusco A., Tagliaferro P., Saez T., Onaivi E.S. Postsynaptic localization of CB2 cannabinoid receptors in the rat hippocampus. Synapse 2008, 62:944-949.
10. Gong J.P., Onaivi E.S., Ishiguro H., Liu Q.R., Tagliaferro P.A., Brusco A., et al. Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res 2006, 1071:10-23.
11. Compton D.R., Gold L.H., Ward S.J., Balster R.L., Martin B.R. Aminoalkylindole analogs: cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinol. J Pharmacol Exp Ther 1992, 263:1118-1126.
12. Martin B.R., Compton D.R., Thomas B.F., Prescott W.R., Little P.J., Razdan R.K., et al. Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs. Pharmacol Biochem Behav 1991, 40:471-478.
13. Rodriguez de Fonseca F., Cebeira M., Fernandez-Ruiz J.J., Navarro M., Ramos J.A. Effects of pre- and perinatal exposure to hashish extracts on the ontogeny of brain dopaminergic neurons. Neuroscience 1991, 43:713-723.
14. Molina-Holgado F., Amaro A., Gonzalez M.I., Alvarez F.J., Leret M.L. Effect of maternal delta 9-tetrahydrocannabinol on developing serotonergic system. Eur J Pharmacol 1996, 316:39-42.
15. Garcia-Gil L., de Miguel R., Romero J., Perez A., Ramos J.A., Fernandez-Ruiz J.J. Perinatal delta9-tetrahydrocannabinol exposure augmented the magnitude of motor inhibition caused by GABA(B), but not GABA(A), receptor agonists in adult rats. Neurotoxicol Teratol 1999, 21:277-283.
16. Vela G., Fuentes J.A., Bonnin A., Fernandez-Ruiz J., Ruiz-Gayo M. Perinatal exposure to delta 9-tetrahydrocannabinol (delta 9-THC) leads to changes in opioid-related behavioral patterns in rats. Brain Res 1995, 680:142-147.
17. Vela G., Martin S., Garcia-Gil L., Crespo J.A., Ruiz-Gayo M., Javier Fernandez-Ruiz J., et al. Maternal exposure to delta9-tetrahydrocannabinol facilitates morphine self-administration behavior and changes regional binding to central mu opioid receptors in adult offspring female rats. Brain Res 1998, 807:101-109.
18. Coffey R.G., Yamamoto Y., Snella E., Pross S. Tetrahydrocannabinol inhibition of macrophage nitric oxide production. Biochem Pharmacol 1996, 52:743-751.
19. Burnette-Curley D., Marciano-Cabral F., Fischer-Stenger K., Cabral G.A. delta-9-Tetrahydrocannabinol inhibits cell contact-dependent cytotoxicity of Bacillus Calmette-Guerin-activated macrophages. Int J Immunopharmacol 1993, 15:371-382.
20. Jeon Y.J., Yang K.H., Pulaski J.T., Kaminski N.E. Attenuation of inducible nitric oxide synthase gene expression by delta 9-tetrahydrocannabinol is mediated through the inhibition of nuclear factor- kappa B/Rel activation. Mol Pharmacol 1996, 50:334-341.
21. Fernandez-Ruiz J., Berrendero F., Hernandez M.L., Ramos J.A. The endogenous cannabinoid system and brain development. Trends Neurosci 2000, 23:14-20.
22. Fernandez-Ruiz J.J., Berrendero F., Hernandez M.L., Romero J., Ramos J.A. Role of endocannabinoids in brain development. Life Sci 1999, 65:725-736.
23. Viveros M.P., Llorente R., Moreno E., Marco E.M. Behavioural and neuroendocrine effects of cannabinoids in critical developmental periods. Behav Pharmacol 2005, 16:353-362.
24. Breder C.D., Saper C.B. Expression of inducible cyclooxygenase mRNA in the mouse brain after systemic administration of bacterial lipopolysaccharide. Brain Res 1996, 713(1-2):64-69.
25. Hawkins R.D., Son H., Arancio O. Nitric oxide as a retrograde messenger during long-term potentiation in hippocampus. Prog Brain Res 1998, 118:155-172.
26. Prast H., Philippu A. Nitric oxide as modulator of neuronal function. Prog Neurobiol 2001, 64(1):51-68.
27. Kolesnikov Y.A., Pick C.G., Pasternak G.W. NG-nitro-l-arginine prevents morphine tolerance. Eur J Pharmacol 1992, 221(2-3):399-400.
28. Xu X., Boshoven W., Lombardo B., Spranger J. Comparison of the amnestic effects of NMDA receptor antagonist MK-801 and nitric oxide synthase inhibitors: L-NAME and L-NOARG in goldfish. Behav Neurosci 1998, 112:892-899.
29. Cuellar B., Fernandez A.P., Lizasoain I., Moro M.A., Lorenzo P., Bentura M.L., et al. Up-regulation of neuronal NO synthase immunoreactivity in opiate dependence and withdrawal. Psychopharmacology (Berl) 2000, 148:66-73.
30. Lysle D.T., How T. Endogenous opioids regulate the expression of inducible nitric oxide synthase by splenocytes. J Pharmacol Exp Ther 1999, 288(2):502-508.
31. O'Dell T.J., Huang P.L., Dawson T.M., Dinerman J.L., Snyder S.H., Kandel E.R., et al. Endothelial NOS and the blockade of LTP by NOS inhibitors in mice lacking neuronal NOS. Science 1994, 265:542-546.
32. Wilson R.I., Yanovsky J., Godecke A., Stevens D.R., Schrader J., Haas H.L. Endothelial nitric oxide synthase and LTP. Nature 1997, 386:338.
33. Everitt B.J., Robbins T.W. Central cholinergic systems and cognition. Annu Rev Psychol 1997, 48:649-684.
34. Compton D.M. Behavior strategy learning in rat: effects of lesions of the dorsal striatum or dorsal hippocampus. Behav Processes 2004, 67(3):335-342.
35. Farr S.A., Flood J.F., Morley J.E. The effect of cholinergic, GABAergic, serotonergic, and glutamatergic receptor modulation on posttrial memory processing in the hippocampus. Neurobiol Learn Mem 2000, 73(2):150-167.
36. Izquierdo I., da Cunha C., Rosat R., Jerusalinsky D., Ferreira M.B., Medina J.H. Neurotransmitter receptors involved in post-training memory processing by the amygdala, medial septum, and hippocampus of the rat. Behav Neural Biol 1992, 58:16-26.
37. Paxinos G., Franklin K.B.J. The mouse brain in stereotaxic coordinates 2001, Academic Press. 2nd Ed.
38. Hiramatsu M., Sasaki M., Kameyama T. Effects of dynorphin A-(1-13) on carbon monoxide-induced delayed amnesia in mice studied in a stepdown type passive avoidance task. Eur J Pharmacol 1995, 282:185-191.
39. Zarrindast M.R., Rezayof A. Morphine state-dependent learning:sensitization and interactions with dopamine receptors. Eur J Pharmacol 2004, 497:197-204.
40. Khavandgar S., Homayoun H., Torkaman-Boutorabi A., Zarrindast M.R. The effects of adenosine receptor agonists and antagonists on morphine state-dependent memory of passive avoidance. Neurobiol Learn Mem 2002, 78:390-405.
41. Homayoun H., Khavandgar S., Zarrindast M.R. Morphine statedependent learning: interactions with ά2-adrenoceptors and acute stress. Behav Pharmacol 2003, 14:41-48.
42. Zarrindast M.R., Torabi M., Rostami P., Fazli-Tabaei S. The effects of histaminergic agents in the dorsal hippocampus of rats in the elevated plus-maze test of anxiety. Pharmacol Biochem Behav 2006, 85:500-506.
43. Vinade E.R., Schmidt A.P., Frizzo M.E., Izquierdo I., Elisabetsky E., Souza D.O. Chronically administered guanosine is anticonvulsant, amnesic and anxiolytic in mice. Brain Research 2003, 977:97-102.
44. Zarrindast M.R., Nouri M., Ahmadi S. Cannabinoid CB1 receptors of the dorsal hippocampus are important for induction of conditioned place preference (CPP) but do not change morphine CPP. Brain Res 2007, 1163:130-137.
45. Roohbakhsh A., Moghaddam A.H., Massoudi R., Zarrindast M.R. Role of dorsal hippocampal cannabinoid receptors and nitric oxide in anxiety like behaviours in rats using the elevated plus-maze test. Clin Exp Pharmacol Physiol 2007, 34:223-229.
46. De Oliveira Alvares L., Genro B.P., Vaz Breda R., Pedroso M.F., Da Costa J.C., Quillfeldt J.A. AM251, a selective antagonist of the CB1 receptor, inhibits the induction of long-term potentiation and induces retrograde amnesia in rats. Brain Res Dev Brain Res 2006, 1075:60-67.
47. De Oliveira Alvares L., Genro B.P., Diehl F., Quillfeldt J.A. Differential role of the hippocampal endocannabinoid system in the memory consolidation and retrieval mechanisms. Neurobiol Learn Mem 2008, 90:1-9.
48. Davies S.N., Pertwee R.G., Riedel G. Functions of cannabinoid receptors in the hippocampus. Neuropharmacology 2002, 42(8):993-1007.
49. Hampson R.E., Deadwyler S.A. Cannabinoids, hippocampal function and memory. Life Sci 1999, 65(6-7):715-723.
50. Hernandez-Tristan R., Arevalo C., Canals S., Leret M.L. The effects of acute treatment with delta9-THC on exploratory behaviour and memory in the rat. J Physiol Biochem 2000, 56:17-24.
51. Lichtman A.H., Dimen K.R., Martin B.R. Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats. Psychopharmacology (Berl) 1995, 119(3):282-290.
52. Da Silva G., Takahashi R.N. SR 141716A prevents delta 9-tetrahydrocannabinol-induced spatial learning deficit in a Morris-type water maze in mice. Prog Neuropsychopharmacol Biol Psychiatry 2002, 26(2):321-325.
53. Kobilo T., Hazvi S., Dudai Y. Role of cortical cannabinoid CB1 receptor in conditioned taste aversion memory. Eur J Neurosci 2007, 25(11):3417-3421.
54. Robinson L., Goonawardena A.V., Pertwee R.G., Hampson R.E., Riedel G. The synthetic cannabinoid HU210 induces spatial memory deficits and suppresses hippocampal firing rate in rats. Br J Pharmacol 2007, 151:688-700.
55. Herkenham M., Lynn A.B., Little M.D., Johnson M.R., Melvin L.S., de Costa B.R., et al. Cannabinoid receptor localization in brain. Proc Natl Acad Sci U S A 1990, 87:1932-1936.
56. Pettit D.A., Harrison M.P., Olson J.M., Spencer R.F., Cabral G.A. Immunohistochemical localization of the neural cannabinoid receptor in rat brain. J Neurosci Res 1998, 51:391-402.
57. Bilkei-Gorzo A., Racz I., Valverde O., Otto M., Michel K., Sastre M., et al. Early age-related cognitive impairment in mice lacking cannabinoid CB1 receptors. Proc Natl Acad Sci U S A 2005, 102:15670-15675.
58. Martin M., Ledent C., Parmentier M., Maldonado R., Valverde O. Involvement of CB1 cannabinoid receptors in emotional behaviour. Psychopharmacology (Berl) 2002, 159:379-387.
59. Varvel S.A., Lichtman A.H. Evaluation of CB1 receptor knockout mice in the Morris water maze. J Pharmacol Exp Ther 2002, 301(3):915-924.
60. Reibaud M., Obinu M.C., Ledent C., Parmentier M., Bohme G.A., Imperato A. Enhancement of memory in cannabinoid CB1 receptor knock-out mice. Eur J Pharmacol 1999, 379:R1-R2.
61. Ferrari F., Ottani A., Vivoli R., Giuliani D. Learning impairment produced in rats by the cannabinoid agonist HU 210 in a water-maze task. Pharmacol Biochem Behav 1999, 64:555-561.
62. Varvel S.A., Hamm R.J., Martin B.R., Lichtman A.H. Differential effects of delta 9-THC on spatial reference and working memory in mice. Psychopharmacology (Berl) 2001, 157:142-150.
63. De Oliveira Alvares L., Pasqualini Genro B., Diehl F., Quillfeldt J.A. Dfferential role of the hippocampal endocannabinoid system in the memory consolidation and retrieval mechanisms. Neurobiol Learn Mem 2008, 90:1-9.
64. Sullivan J.M. Mechanisms of cannabinoid-receptor-mediated inhibition of synaptic transmission in cultured hippocampal pyramidal neurons. J Neurophysiol 1999, 82(3):1286-1294.
65. Katona I., Urban G.M., Wallace M., Ledent C., Jung K.M., Piomelli D., et al. Molecular composition of the endocannabinoid system at glutamatergic synapses. J Neurosci 2006, 26:5628-5637.
66. Domenici M.R., Azad S.C., Marsicano G., Schierloh A., Wotjak C.T., Dodt H.U., et al. Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamatergic synaptic transmission. J Neurosci 2006, 26:5794-5799.
67. Overton D.A. Comparison of the degree of discriminability of various drugs using the T-maze drug discrimination paradigm. Psychopharmacology (Berl) 1982, 76(4):385-395.
68. Shulz D.E., Sosnik R., Ego V., Haidarliu S., Ahissar E. A neuronal analogue of state-dependent learning. Nature 2000, 403:549-553.
69. Hiramatsu M., Nabeshima T., Kameyama T. Involvement of opioid receptors in hypo- and hyperthermic effects induced by phencyclidine in mice. J Pharmacobiodyn 1986, 9(5):466-472.
70. Rezayof A., Alijanpour S., Zarrindast M.R., Rassouli Y. Ethanol state-dependent memory: involvement of dorsal hippocampal muscarinic and nicotinic receptors. Neurobiol Learn Mem 2008, 89:441-447.
71. Clarke J.R., Rossato J.I., Monteiro S., Bevilaqua L.R., Izquierdo I., Cammarota M. Posttraining activation of CB1 cannabinoid receptors in the CA1 region of the dorsal hippocampus impairs object recognition long-term memory. Neurobiol Learn Mem 2008, 90:374-381.
72. Bruins Slot L.A., Colpaert F.C. Recall rendered dependent on an opiate state. Behav Neurosci 1999, 113(2):337-344.
73. Bruins Slot L.A., Colpaert F.C. Opiate states of memory: receptor mechanisms. J Neurosci 1999, 19(23):10520-10529.
74. Zarrindast M.R., Jafari-Sabet M., Rezayat M., Djahanguiri B., Rezayof A. Involvement of NMDA receptors in morphine state-dependent learning in mice. Int J Neurosci 2006, 116:731-743.
75. Zarrindast M.R., Askari E., Khalilzadeh A., Nouraei N. Morphine state-dependent learning sensitization and interaction with nitric oxide. Pharmacology 2006, 78:66-71.
76. Zarrindast M.R., Noorbakhshnia M., Motamedi F., Haeri-Rohani A., Rezayof A. Effect of the GABAergic system on memory formation and state-dependent learning induced by morphine in rats. Pharmacology 2006, 76:93-100.
77. Zarrindast M.R., Kangarlu-Haghighi K., Khalilzadeh A., Fazli-Tabaei S. Influence of intracerebroventricular administration of cannabinergic drugs on morphine state-dependent memory in the step-down passive avoidance test. Behav Pharmacol 2006, 17:231-237.
78. Zarrindast M.R., Bananej M., Khalilzadeh A., Fazli-Tabaei S., Haeri-Rohani A., Rezayof A. Influence of intracerebroventricular administration of dopaminergic drugs on morphine state-dependent memory in the step-down passive avoidance test. Neurobiol Learn Mem 2006, 86:286-292.
79. Zarrindast M.R., Rezayof A. Morphine state-dependent learning: sensitization and interactions with dopamine receptors. Eur J Pharmacol 2004, 497(2):197-204.
80. Zarrindast M.R., Farahmandfar M., Rostami P., Rezayof A. The influence of central administration of dopaminergic and cholinergic agents on morphine-induced amnesia in morphine-sensitized mice. J Psychopharmacol 2006, 20:59-66.
81. Zarrindast M.R., Khalilzadeh A., Malekmohammadi N., Fazli-Tabaei S. Influence of morphine- or apomorphine-induced sensitization on histamine state-dependent learning in the step-down passive avoidance test. Behav Brain Res 2006, 171:50-55.
82. Khalilzadeh A., Zarrindast M.R., Djahanguiri B. Effects of intracerebroventricular administration of ultra low doses of histaminergic drugs on morphine state-dependent memory of passive avoidance in mice. Behav Brain Res 2006, 166(1):184-187.
83. Zarrindast M.R., Khalilzadeh A., Rezayat S.M., Sahebgharani M., Djahanguiri B. Influence of intracerebroventricular administration of histaminergic drugs on morphine state-dependent memory in the step-down passive avoidance test. Pharmacology 2005, 74:106-112.
84. Zarrindast M.R., Nouraei N., Khallilzadeh A., Askari E. Influence of acute and sub-chronic nicotine pretreatment on morphine state-dependent learning. Behav Brain Res 2006, 173:268-273.
85. Jafari M.R., Zarrindast M.R., Djahanguiri B. Influence of cholinergic system modulators on morphine state-dependent memory of passive avoidance in mice. Physiol Behav 2006, 88(1-2):146-151.
86. Ahmadi S., Zarrindast M.R., Nouri M., Haeri-Rohani A., Rezayof A. N-Methyl-D-aspartate receptors in the ventral tegmental area are involved in retrieval of inhibitory avoidance memory by nicotine. Neurobiol Learn Mem 2007, 88:352-358.
87. Sutherland R.J., McDonald R.J. Hippocampus, amygdala, and memory deficits in rats. Behav Brain Res 1990, 37(1):57-79.
88. Packard M.G., White N.M. Dissociation of hippocampus and caudate nucleus memory systems by posttraining intracerebral injection of dopamine agonists. Behav Neurosci 1991, 105(2):295-306.
89. Squire L.R., Ojemann J.G., Miezin F.M., Petersen S.E., Videen T.O., Raichle M.E. Activation of the hippocampus in normal humans: a functional anatomical study of memory. Proc Natl Acad Sci U S A 1992, 89:1837-1841.
90. Wan R.Q., Pang K., Olton D.S. Hippocampal and amygdaloid involvement in nonspatial and spatial working memory in rats: effects of delay and interference. Behav Neurosci 1994, 108(5):866-882.
91. Shen M., Piser T.M., Seybold V.S., Thayer S.A. Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. J Neurosci 1996, 16:4322-4334.
92. Baratti C.M., Kopf S.R. A nitric oxide synthase inhibitor impairs memory storage in mice. Neurobiol Learn Mem 1996, 65(3):197-201.
93. Holscher C., Rose S.P. An inhibitor of nitric oxide synthesis prevents memory formation in the chick. Neurosci Lett 1992, 145(2):165-167.
94. Bohme G.A., Bon C., Lemaire M., Reibaud M., Piot O., Stutzmann J.M., et al. Altered synaptic plasticity and memory formation in nitric oxide synthase inhibitor-treated rats. Proc Natl Acad Sci U S A 1993, 90:9191-9194.
95. Schuman E.M., Madison D.V. A requirement for the intercellular messenger nitric oxide in long-term potentiation. Science 1991, 254(5037):1503-1506.
96. Di Marzo V., Fontana A., Cadas H., Schinelli S., Cimino G., Schwartz J.C., et al. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 1994, 372:686-691.
97. Stefano G.B., Hartman A., Bilfinger T.V., Magazine H.I., Liu Y., Casares F., et al. Presence of the mu3 opiate receptor in endothelial cells. Coupling to nitric oxide production and vasodilation. J Biol Chem 1995, 270:30290-30293.
98. Liu Y., Shenouda D., Bilfinger T.V., Stefano M.L., Magazine H.I., Stefano G.B. Morphine stimulates nitric oxide release from invertebrate microglia. Brain Res 1996, 722:125-131.
99. Baratti C.M., Boccia M.M. Effects of sildenafil on long-term retention of an inhibitory avoidance response in mice. Behav Pharmacol 1999, 10(8):731-737.
100. Garthwaite J., Garthwaite G., Palmer R.M., Moncada S. NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. Eur J Pharmacol 1989, 172:413-416.
101. Telegdy G., Kokavszky R. The role of nitric oxide in passive avoidance learning. Neuropharmacology 1997, 36(11-12):1583-1587.